Medicine News and Research

RSS

Gamida Cell and Cellerixon collaborate to develop new line of cell therapeutics

Gamida Cell Ltd. and Cellerix, S.A. announced today that the companies are collaborating on a feasibility study to evaluate the added value of combining the proprietary technologies of each.

21 Oct 2009

Professor secures grant for further research on immunotherapy strategies

Venuprasad K. Poojary, Ph.D., assistant professor at the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, has secured a two-year federal grant for almost $1 million to further his research into creating more effective immunotherapy strategies for cancer treatment.

21 Oct 2009

Study reveals a dramatic increase in TTB cases

Babesiosis is a potentially dangerous parasitic disease transmitted by ticks and is common in the Northeast and the upper Midwest. Babesia lives inside of red blood cells, meaning it can also be transmitted through a blood transfusion from an infected but otherwise asymptomatic blood donor.

21 Oct 2009

Kinetic Concepts announces fiscal 2009 third-quarter results

Kinetic Concepts, Inc. today reported third quarter 2009 total revenue of $504.4 million, compared to $503.3 million reported for the third quarter of 2008. Total revenue for the first nine months of 2009 was $1.466 billion, up 6% from the prior-year period. Foreign currency exchange movements negatively impacted total revenue for the third quarter and first nine months of 2009 by approximately 1% and 3%, respectively, compared to the corresponding periods of the prior year.

21 Oct 2009

£17,000 grant to university researcher for breast cancer research

A researcher at the University of Sheffield is set to investigate whether women with a mutation in a gene that prevents folate (vitamin B9) working effectively may be at increased risk of breast cancer.

21 Oct 2009

Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis

Bristol-Myers Squibb Company announced today that new clinical data support continued development of a subcutaneous administration of ORENCIA® (abatacept) for patients with moderate to severe rheumatoid arthritis.

21 Oct 2009

Philadelphia's Franklin Institute to exhibit Gunther von Hagens' Body Worlds 2 & The Brain

Gunther von Hagens' Body Worlds 2 & The Brain made its debut at Philadelphia's Franklin Institute on October 17, and will be one of many points of interest for visitors eager to explore the area's vast array of scientific treasures.

21 Oct 2009

Carcinoembryonic antigen co-discoverer Dr. Phil Gold to be inducted into The Canadian Medical Hall of Fame

Prof. Heather Munroe-Blum, Principal and Vice-Chancellor of McGill University, and the Hon. Arthur T. Porter, Director General and CEO of the McGill University Health Centre (MUHC), welcome the news that Dr. Phil Gold is to be inducted into The Canadian Medical Hall of Fame. In 1965, Dr. Gold co-discovered the carcinoembryonic antigen (CEA), the first clinically useful human tumour marker that revolutionized the diagnosis and management of cancer.

21 Oct 2009

Autobiography of a cardiologist "Doctor of the Heart" published

Doctor of the Heart: My Life in Medicine is the autobiography of Isadore Rosenfeld, MD, world-renowned cardiologist, best-selling author, and popular television commentator. Published by Mary Ann Liebert, Inc., Dr. Rosenfeld's book is a remarkable account of his long and extraordinary career (www.liebertpub.com/heart).

21 Oct 2009

New tools needed to identify men and women at risk for the most aggressive cancers

Twenty years of screening for breast and prostate cancer - the most diagnosed cancer for women and men - have not brought the anticipated decline in deaths from these diseases, argue experts from the University of California, San Francisco and the University of Texas Health Science Center at San Antonio in an opinion piece published in the "Journal of the American Medical Association."

21 Oct 2009

Doctor of Dental Medicine program to be launched in Utah

The University of Southern Nevada (USN), a private, non-profit institution of higher education, announced today plans to expand its College of Dental Medicine by starting a Doctor of Dental Medicine (DMD) program at the university’s campus located at 10920 South River Front Parkway in South Jordan, Utah. The university expects to admit its first class in fall 2011.

21 Oct 2009

Interim study analysis comparing MENOPUR with rFSH in GnRH Antagonist IVF cycles

Ferring Pharmaceuticals presented an interim study analysis indicating that MENOPUR® (menotropins for injection, USP) is effective in in vitro fertilization (IVF) cycles using a gonadotropin-releasing hormone (GnRH) antagonist. The results were presented in a poster at the 65th Annual Meeting of the American Society for Reproductive Medicine (ASRM) in Atlanta, October 17-21, 2009.

21 Oct 2009

V8 100% vegetable juice aids in weight loss and lowers blood pressure

Decades of studies have documented the link between eating a diet rich in vegetables and multiple health benefits, yet nearly eight out of 10 people worldwide fall short of the daily recommendation.

21 Oct 2009

Controlled formation of patchy particles may serve as drug-delivery vehicles to combat disease

Physicists, chemists and engineers at the University of Pennsylvania have demonstrated a novel method for the controlled formation of patchy particles, using charged, self-assembling molecules that may one day serve as drug-delivery vehicles to combat disease and perhaps be used in small batteries that store and release charge.

21 Oct 2009

Book reviews applications of genetic research in the fields of exercise science and sports medicine

This publication reviews past, current and future applications of genetic research in the fields of exercise science and sports medicine. It highlights ethical concerns, potential clinical applications and exploitation of genetic information. The authors, an interdisciplinary group of experts comprising clinicians, exercise scientists, human geneticists and other biological scientists, present an integrated and holistic understanding of the field to the reader.

21 Oct 2009

Class action lawsuit by patients who received high dosage of radiation during their CT brain perfusion scans

A class action lawsuit (Case #BC4241898) was just filed in Los Angeles Superior Court against Cedars Sinai Medical Center, GE Healthcare, Inc., and GE Healthcare Technologies on behalf of patients who received 8-times the approved dosage of radiation during their CT brain perfusion scans to diagnose strokes.

21 Oct 2009

UF scientists shed new light on old medical procedure

You might not know what it's called, but if you've had general anesthesia before surgery, especially after an accident, it is likely you have received Sellick's maneuver. That's when fingers are pressed against a patient's throat to prevent regurgitation and spilling of stomach contents into the airway and lungs while anesthesia is being administered.

21 Oct 2009

Community Health Care partners with SUNRx to provide discount medication program

Community Health Care, a provider of comprehensive healthcare services to uninsured and underinsured residents in southern New Jersey, today announced a partnership with SUNRx, a Mt. Laurel-based health technology company, to offer discount medications to tens of thousands of families in the Garden State beginning in October.

21 Oct 2009

Drug abuse expert Dr. Drew Pinsky and the Five Moms join in fight against OTC cough medicine abuse

Dr. Drew Pinsky, a nationally renowned drug abuse expert, and the Five Moms, five exceptional women dedicated to spreading the word about the dangers of cough medicine abuse, are speaking out to educate parents and congressional staff on Capitol Hill about the issue of over-the-counter (OTC) cough medicine abuse among teens and how to prevent it through education.

21 Oct 2009

No significant differences in pregnancy outcomes with different progesterone formulations

A retrospective analysis, conducted at a large infertility clinic between January 2003 and December 2008, demonstrated that there were no significant differences in pregnancy outcomes with three different progesterone formulations for women aged 35 to 40 undergoing in vitro fertilization-embryo transfer (IVF-ET) procedures. These data were presented at the American Society for Reproductive Medicine (ASRM) annual meeting in Atlanta.

21 Oct 2009

Medicine News and Research

Gamida Cell and Cellerixon collaborate to develop new line of cell therapeutics

Professor secures grant for further research on immunotherapy strategies

Study reveals a dramatic increase in TTB cases

Kinetic Concepts announces fiscal 2009 third-quarter results

£17,000 grant to university researcher for breast cancer research

Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis

Philadelphia's Franklin Institute to exhibit Gunther von Hagens' Body Worlds 2 & The Brain

Carcinoembryonic antigen co-discoverer Dr. Phil Gold to be inducted into The Canadian Medical Hall of Fame

Autobiography of a cardiologist "Doctor of the Heart" published

New tools needed to identify men and women at risk for the most aggressive cancers

Doctor of Dental Medicine program to be launched in Utah

Interim study analysis comparing MENOPUR with rFSH in GnRH Antagonist IVF cycles

V8 100% vegetable juice aids in weight loss and lowers blood pressure

Controlled formation of patchy particles may serve as drug-delivery vehicles to combat disease

Book reviews applications of genetic research in the fields of exercise science and sports medicine

Class action lawsuit by patients who received high dosage of radiation during their CT brain perfusion scans

UF scientists shed new light on old medical procedure

Community Health Care partners with SUNRx to provide discount medication program

Drug abuse expert Dr. Drew Pinsky and the Five Moms join in fight against OTC cough medicine abuse

No significant differences in pregnancy outcomes with different progesterone formulations

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News